Health Care
Alliance For Artificial Intelligence In Healthcare
BALTIMORE, MD
Total revenue
$216K
Total expenses
$201K
Net assets
—
Grants received
—
EIN
832623146
Tax year
2024
Mission
The aaih is an international 501(c)4 not-for-profit multi-stakeholder advocacy organization, launched in 2019 to promote scientific, legistlative, and regulatory initiatives necessary for the development, accessibility, and implementation of artificial intelligence (ai) powered healthcare solutions. Our mission is to enable the advancement and responsible use of ai in healthcare to improve patient's lives by focusing on resolution of the sectors most pressing and significant issues for patients and developer. It advances these goals by working collectively to identify and address industry wide concerns, one of which is the intersection of ai and intellectual property.
Programs
3 programs
Policy and regulatory: the policy and regulatory working group is focused on engagement with regional and international governing and regulatory bodies, such as cms, ema, health canada, fda etc. In addition, the prwg is responsible for developing a cohesive strategy for aaih legislative and policy advocacy. Accomplishments: a. Coordinated and cohosted member sessions on ip issues around ai/ml in healthcare b. Held members regulatory affairs meetings to exchange information and views on regulators activities and industry developments.
Data science, technology and standards: the dsts working group is focused on initiatives dedicated to fostering the development of specific technology sectors through consideration of key questions around data access, standards and data integrity for ai powered healthcare solutions. Accomplishments: a. Hosted webinar on federated data approaches to data sharing b. Sponsored regular working group meetings on ai/ml use for clinical applications c. Actively engaged with standards development organizations through public consortia and private discussions.
Enable the advancement and responsible use of ai in healthcare to improve patients lives by focusing on resolution of the sectors most pressing and significant issues for patients and developers. It advances these goals by working collectively to identify and address industry wide concerns, one of which is the intersection of ai and intellectual property. Accomplishments: a. Launched projects focused on collaborations around disease data access b. Developed framework for ai/ml sector performance metric.
Financials
FY 2024
Revenue
Expenses
People
14 listed
ELAINE HAMM
EXECUTIVE DIRECTOR
$132K
10 hrs/wk
STACIE CALAD-THOMSON
VICE-CHAIRPERSON
—
1 hrs/wk
MARIA LUISA PINEDA
SECRETARY
—
1 hrs/wk
JAMES ZANEWICZ
TREASURER
—
1 hrs/wk
NAHEED KURJI
DIRECTOR
—
0.5 hrs/wk
SARAH BENSON-KONFORTY
DIRECTOR
—
0.5 hrs/wk
ESTHER BLEICHER
DIRECTOR
—
0.5 hrs/wk
MUSTAQHUSAID KAZI
CHAIRPERSON
—
5 hrs/wk
JOSEPH LEHAR
DIRECTOR
—
0.5 hrs/wk
BRUCE PRESS
DIRECTOR
—
0.5 hrs/wk
RAFAEL ROSENGARTEN
DIRECTOR
—
0.5 hrs/wk
ANGELA WILKENS
DIRECTOR
—
0.5 hrs/wk
ALEX ZHAVORONKOV
DIRECTOR
—
0.5 hrs/wk
ARNAUB CHATTERJEE
DIRECTOR
—
0.5 hrs/wk